Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H41N5O5S |
Molecular Weight | 499.667 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](S)CCN1C(=O)N(C)C(C)(C)C1=O)C(C)(C)C
InChI
InChIKey=GTXSRFUZSLTDFX-HRCADAONSA-N
InChI=1S/C23H41N5O5S/c1-13(2)12-14(17(29)26-16(19(31)24-8)22(3,4)5)25-18(30)15(34)10-11-28-20(32)23(6,7)27(9)21(28)33/h13-16,34H,10-12H2,1-9H3,(H,24,31)(H,25,30)(H,26,29)/t14-,15-,16+/m0/s1
Molecular Formula | C23H41N5O5S |
Molecular Weight | 499.667 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 3 / 3 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Rebimastat (BMS-275291) is a broad-spectrum matrix metalloproteinase (MMP) inhibitor free from toxicity-related inhibition of sheddases (cleaving membrane proteins at the cell surface). This MMP2 and MMP9 inhibitor may stop the growth of cancers by stopping blood flow to the tumor (stopping them from dividing). It might also block the enzymes necessary for growth of the tumor cell. Multiple phase II trials and a phase III clinical trial have been completed, testing the efficacy and safety of the compound in prostate cancer, HIV-related Kaposi’s Sarcoma, non-small cell lung cancer (phase II and III) and breast cancer.
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:38:55 GMT 2023
by
admin
on
Fri Dec 15 15:38:55 GMT 2023
|
Record UNII |
1B47R6ZX4K
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1970
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9913881
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
1B47R6ZX4K
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
DTXSID80948835
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
100000126188
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
259188-38-0
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
MM-64
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
SUB32855
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
8167
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
CHEMBL76222
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
C1875
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY | |||
|
DB06573
Created by
admin on Fri Dec 15 15:38:55 GMT 2023 , Edited by admin on Fri Dec 15 15:38:55 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|